免费领取！《2025中国合成生物制造产业发展白皮书》

Core Viewpoint - The article emphasizes the rising importance of biomanufacturing as a strategic and innovative field that disrupts traditional production methods, presenting it as a new growth point for optimizing industrial structure and transforming economic models [1]. Group 1: Current Status and Trends - The "2025 China Synthetic Biomanufacturing Industry Development White Paper" was officially released on August 1, highlighting the current state and trends of biomanufacturing [1]. - The report analyzes the global biomanufacturing industry, including key platform facilities and a comparative study of the US and China in this sector [7]. Group 2: Policy Landscape - The white paper outlines major policies affecting biomanufacturing both domestically and internationally for the years 2024-2025 [7]. Group 3: Industry Map and Applications - It provides a comprehensive map of the Chinese biomanufacturing industry and details the industry chain along with key application areas such as pharmaceuticals, food, personal care, agriculture, chemicals, materials, and energy [7]. Group 4: Key Enterprises - The report identifies ten leading enterprises in the Chinese biomanufacturing sector, including companies like Kasei Biotech and Huaheng Biotech, among others [8]. Group 5: Company Strategies - It summarizes the synthetic biology strategies of 15 listed companies and highlights 20 popular products associated with these companies [8]. Group 6: Investment and Financing - The document discusses the investment and financing situation in the domestic synthetic biology sector for the period of 2024 to mid-2025 [8]. Group 7: Challenges and Recommendations - The report addresses the challenges faced by the biomanufacturing industry in China and offers targeted policy recommendations for industry stakeholders [8].